Biobeat Secures $50 Million Series B Financing to Advance Commercialization of its Patch-worn, Cuff-less 24-hour Ambulatory Blood Pressure Monitor 
ESO’s Garrett Hall Awarded Joseph J. Tepas, MD Award by Pediatric Trauma Society
Annual award recognizes excellence in trauma-related research; paper based on racial disparities and safety concerns around prehospital analgesia for children...
NextGen Healthcare Spotlights Patient-Provider Engagement at 24th Annual User Group Meeting
Industry Experts Convened at UGM ’21 to Share Technology and Clinical Insights and Best Practices; Announces Six New “Excellence in...
Nanox to Introduce New Nanox.ARC Procedures, Highlight Nanox.AI Software Solutions at 2021 Radiology Society of North America Annual Meeting
First-ever unveiling of Nanox.ARC new features and procedures Nanox.AI to feature AI-enabled medical imaging software solutions Shamir Medical Center Diagnostic...
Cloud DX to Participate in Upcoming Investor Events
WATERLOO, ON / ACCESSWIRE / November 11, 2021 / Cloud DX (TSXV:CDX)(OTCQB:CDXFF), As a leading provider of Virtual Care as...
Imaging Biometrics and St. Jude Children’s Hospital Enter Agreement
IB Zero G™ Technology May Benefit Imaging in Pediatric PatientsMILWAUKEE, WI / ACCESSWIRE / November 11, 2021 / IQ-AI Limited...
Innovation Pharmaceuticals Announces Topline Results from Phase 2 Clinical Trial of Brilacidin for COVID-19
WAKEFIELD, MA / ACCESSWIRE / November 11, 2021 / Innovation Pharmaceuticals (OTCQB:IPIX) ("the Company"), a clinical stage biopharmaceutical company, today...
Jupiter Wellness Completes Pre-IND meeting with the U.S. Food & Drug Administration for JW-100 in the Treatment of Eczema
JUPITER, FL / ACCESSWIRE / November 11, 2021 / Jupiter Wellness, Inc. (NASDAQ:JUPW), a clinical stage company developing cannabinoid receptor...
Aptevo Therapeutics Announces Preclinical Data for Bispecific Antibody APVO603 at the Society for Immunology in Cancer Annual Meeting
Preclinical data demonstrates inhibited tumor cell growth in vitro when paired with a T-cell engager bispecificSEATTLE, WA / ACCESSWIRE /...
StageZero Life Sciences and Teen Cancer America Join Forces to Help Improve Outcomes for Adolescents and Young Adults with Cancer
Activities will include a national educational awareness campaign, health economics research, and clinical studies aimed at earlier detection of testicular,...
Dynatronics Corporation Reports First Quarter Financial Results and Business Highlights
EAGAN, MN / ACCESSWIRE / November 11, 2021 / Dynatronics Corporation (NASDAQ:DYNT), a leading manufacturer of athletic training, physical therapy,...
iZafe Group AB Announces New Chief Marketing Officer Carl-Fredrik Bothén
STOCKHOLM, SWEDEN / ACCESSWIRE / November 11, 2021 / iZafe Group (STO:IZAFE-B)Stockholm, Sweden, iZafe Group AB (publ) ("iZafe" or "the...
Syneos Health to Present at Upcoming Investor Conferences
MORRISVILLE, N.C., Nov. 11, 2021 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced...
Adaptimmune Reports Positive Results from its Pivotal SPEARHEAD-1 Trial in Patients with Synovial Sarcoma and MRCLS at CTOS
- SPEARHEAD-1 trial will meet its primary endpoint and data will be used to support BLA filing for afami-cel next...
Zealand Pharma Presents Financial Results for the First Nine Months of 2021; Provides Updates on Commercial Launch and Timing for Congenital Hyperinsulinism and Short Bowel Syndrome Phase Three Clinical Studies
Company announcement – No. 67/ 2021 Interim report for 9M 2021 Zealand Pharma Presents Financial Results for the First Nine Months...
Stereotaxis Reports 2021 Third Quarter Financial Results
ST. LOUIS, Nov. 11, 2021 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the...
Rapid Therapeutic Science Laboratories Secures Upgraded Laboratory and Manufacturing Facility
DALLAS, Nov. 11, 2021 (GLOBE NEWSWIRE) -- Rapid Therapeutics Science Laboratories (OTC: RTSL) ("Rapid Therapeutic'' or the "Company"), a growth-oriented...
Rafael Pharmaceuticals Announces First Patient Enrolled in APOLLO 613 Phase 1/2 Clinical Trial of CPI-613® (Devimistat) in Patients with Relapsed Clear Cell Sarcoma
New Trial Sites Open at Cleveland Clinic Children’s and University of MichiganCRANBURY, N.J., Nov. 11, 2021 (GLOBE NEWSWIRE) -- Rafael...
ABVC Biopharma Receives Additional $4,245,000 from Exercise of Warrants, Total Capital from Public Offering Increases to Approx. $11.1M
FREMONT, CA, Nov. 11, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- ABVC BioPharma, Inc.(Nasdaq: ABVC), a biotechnology company specializing in botanically based...
Ceapro Inc. Provides Update on Development of an Inhalable Therapeutic Using Yeast Beta Glucan Processed with Pressurized Gas eXpanded Technology (PGX-YBG)
McMaster’s research team discovers new mechanism of action for PGX-YBG PGX-YBG demonstrates ability to reprogram macrophages on its own PGX-YBG...
Vericel to Present at the Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health and Services Forum on November 18th, 2021
CAMBRIDGE, Mass., Nov. 11, 2021 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine...